In a long-term clinical trial, a responsive neurostimulation system was shown to reduce seizures and improve quality of life in patients with drug-resistant epilepsy. Furthermore, these effects persisted over an extended time period. Will neurostimulation close the treatment gap for patients with refractory epilepsy?
K.V. has received personal compensation for consulting from Cyberonics. P.B. has received personal compensation for consulting from Cyberonics, Medtronic and UCB. K.V and P.B. have received research support (including for clinical trials) through their institution from Cerbomed, Cyberonics, Medtronic, Neurosigma and UCB.
